These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 27372043

  • 1. Association between long-term prescription of aldosterone antagonist and the progression of heart failure with preserved ejection fraction in hypertensive patients.
    Gu J, Fan YQ, Han ZH, Fan L, Bian L, Zhang HL, Xu ZJ, Yin ZF, Xie YS, Zhang JF, Wang CQ.
    Int J Cardiol; 2016 Oct 01; 220():56-60. PubMed ID: 27372043
    [Abstract] [Full Text] [Related]

  • 2. Long-term prescription of beta-blocker delays the progression of heart failure with preserved ejection fraction in patients with hypertension: A retrospective observational cohort study.
    Gu J, Fan YQ, Bian L, Zhang HL, Xu ZJ, Zhang Y, Chen QZ, Yin ZF, Xie YS, Wang CQ.
    Eur J Prev Cardiol; 2016 Sep 01; 23(13):1421-8. PubMed ID: 26915580
    [Abstract] [Full Text] [Related]

  • 3. Effects of spironolactone treatment in elderly women with heart failure and preserved left ventricular ejection fraction.
    Kurrelmeyer KM, Ashton Y, Xu J, Nagueh SF, Torre-Amione G, Deswal A.
    J Card Fail; 2014 Aug 01; 20(8):560-8. PubMed ID: 24905296
    [Abstract] [Full Text] [Related]

  • 4. Association between long-term prescription of febuxostat and the progression of heart failure with preserved ejection fraction in patients with hypertension and asymptomatic hyperuricemia.
    Pan JA, Lin H, Wang CQ, Zhang JF, Gu J.
    Heart Vessels; 2020 Oct 01; 35(10):1446-1453. PubMed ID: 32430700
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Association between long-term prescription of metformin and the progression of heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus and hypertension.
    Gu J, Yin ZF, Zhang JF, Wang CQ.
    Int J Cardiol; 2020 May 01; 306():140-145. PubMed ID: 31711850
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of systolic and diastolic properties of hypertensive heart failure using speckle-tracking echocardiography with high volume rates.
    Minatoguchi S, Kawasaki M, Tanaka R, Yoshizane T, Ono K, Saeki M, Nagaya M, Sato H, Nishigaki K, Noda T, Zile MR, Minatoguchi S.
    Heart Vessels; 2017 Oct 01; 32(10):1202-1213. PubMed ID: 28638961
    [Abstract] [Full Text] [Related]

  • 13. Differential interaction of clinical characteristics with key functional parameters in heart failure with preserved ejection fraction--results of the Aldo-DHF trial.
    Edelmann F, Gelbrich G, Duvinage A, Stahrenberg R, Behrens A, Prettin C, Kraigher-Krainer E, Schmidt AG, Düngen HD, Kamke W, Tschöpe C, Herrmann-Lingen C, Halle M, Hasenfuss G, Wachter R, Pieske B.
    Int J Cardiol; 2013 Nov 30; 169(6):408-17. PubMed ID: 24182675
    [Abstract] [Full Text] [Related]

  • 14. Effect of spironolactone on diastolic function in hypertensive left ventricular hypertrophy.
    Gupta A, Schiros CG, Gaddam KK, Aban I, Denney TS, Lloyd SG, Oparil S, Dell'Italia LJ, Calhoun DA, Gupta H.
    J Hum Hypertens; 2015 Apr 30; 29(4):241-6. PubMed ID: 25231508
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial.
    Shah AM, Claggett B, Sweitzer NK, Shah SJ, Anand IS, O'Meara E, Desai AS, Heitner JF, Li G, Fang J, Rouleau J, Zile MR, Markov V, Ryabov V, Reis G, Assmann SF, McKinlay SM, Pitt B, Pfeffer MA, Solomon SD.
    Circ Heart Fail; 2014 Sep 30; 7(5):740-51. PubMed ID: 25122186
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Efficacy and safety of long-term application of spironolactone in patients with moderate and severe chronic heart failure receiving optimal therapy].
    Skvortsov AA, Mareev VY, Chelmakina SM, Baklanova NA, Belenkov IuN.
    Kardiologiia; 2007 Sep 30; 47(10):12-23. PubMed ID: 18260939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.